Release of C-type particles from normal rat thymus cultures and those infected with Moloney leukemia virus.
D000818:Animals; D001681:Biological Assay; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D046508:Culture Techniques; D003561:Cytarabine / Q000494:pharmacology; D004279:DNA, Viral / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D007106:Immune Sera; D051379:Mice; D008854:Microscopy, Electron; D008979:Moloney murine leukemia virus / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism* / Q000472:pathogenicity; D012367:RNA, Viral / Q000378:metabolism; D051381:Rats; D013057:Spectrum Analysis; D013950:Thymus Gland / Q000378:metabolism / Q000382:microbiology; D014316:Tritium; D014466:Ultraviolet Rays; D014529:Uridine / Q000378:metabolism; D014764:Viral Proteins / Q000302:isolation & purification
D004279:DNA, Viral; D007106:Immune Sera; D012367:RNA, Viral; D014764:Viral Proteins; D005467:Floxuridine; D003561:Cytarabine; D014316:Tritium; D003609:Dactinomycin; D014529:Uridine